Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience

Table 3

MRONJ staging in oncologic patients.

Antiresorptive drug	AAOMS staging system [5]				Dimensional staging system [14]
	Stage 0	Stage I	Stage II	Stage III	Stage 0	Stage I	Stage II	Stage III
Zoledronate	1	13	126	76	1	22	66	127
Denosumab			4	7			3	8
Zoledronate + denosumab			2	1			1	2
Clodronate			4			2	1	1
Risedronate		2	1			1		2
Ibandronate			1				1
Pamidronate		1					1